• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Introduction to N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide (CAS No. 865604-32-6)

N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide, identified by its CAS number 865604-32-6, is a significant compound in the realm of pharmaceutical chemistry. This compound belongs to the class of imidazopyridine derivatives, which have garnered considerable attention due to their diverse biological activities and potential therapeutic applications. The structural features of this molecule, particularly the presence of a bromo substituent on the imidazopyridine ring and a trifluoroacetamide moiety, contribute to its unique chemical properties and reactivity.

The imidazopyridine scaffold is a privileged structure in medicinal chemistry, known for its ability to interact with various biological targets. The bromo group at the 7-position of the imidazopyridine ring enhances the electrophilicity of the molecule, making it a versatile intermediate for further functionalization. This property is particularly valuable in synthetic chemistry, where such intermediates can be readily incorporated into more complex molecular architectures.

The trifluoroacetamide group appended to the molecule introduces additional electronic and steric effects that can influence both the solubility and bioavailability of the compound. Fluorinated amides are commonly employed in drug design due to their ability to improve metabolic stability and binding affinity. The presence of fluorine atoms can also modulate the pharmacokinetic profile of a drug candidate by affecting its lipophilicity and metabolic pathways.

In recent years, there has been a growing interest in developing novel therapeutic agents based on imidazopyridine derivatives. These compounds have shown promise in various preclinical studies as potential treatments for a range of diseases, including cancer, inflammation, and infectious disorders. The bromo-substituted imidazopyridines have been particularly studied for their anti-cancer properties. Researchers have demonstrated that these compounds can inhibit the activity of key enzymes involved in tumor growth and proliferation.

One notable area of research involves the use of N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide as a scaffold for developing small-molecule inhibitors targeting specific protein kinases. Protein kinases are critical enzymes in cellular signaling pathways and are often dysregulated in cancer cells. By designing molecules that selectively inhibit these kinases, researchers aim to disrupt aberrant signaling networks that contribute to tumor growth. Preliminary studies have shown that derivatives of this compound can effectively block the activity of several kinases relevant to cancer progression.

The trifluoroacetamide moiety plays a crucial role in enhancing the binding affinity of these inhibitors. Fluorine atoms can form strong hydrogen bonds with acceptor groups in protein targets, thereby increasing the potency of the drug candidate. Additionally, the electron-withdrawing nature of fluorine can stabilize positive charges on key functional groups within the molecule, further improving its interaction with biological targets.

Another area where N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide has shown promise is in the development of anti-inflammatory agents. Chronic inflammation is a hallmark of many diseases, including arthritis and autoimmune disorders. Researchers have identified that certain imidazopyridine derivatives can modulate inflammatory pathways by inhibiting key pro-inflammatory cytokines and enzymes. The bromo group on the imidazopyridine ring appears to enhance the anti-inflammatory effects by facilitating interactions with specific binding sites on target proteins.

The synthesis of N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The bromination step at the 7-position of the imidazopyridine ring is particularly critical and must be performed under controlled conditions to avoid unwanted side reactions. Once brominated, the introduction of the trifluoroacetamide group typically involves nucleophilic substitution or condensation reactions with appropriate reagents.

The use of advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) is essential for characterizing the structure of this compound. These techniques provide detailed information about the chemical environment of each atom in the molecule, confirming its identity and purity. Additionally, computational methods such as molecular modeling can be employed to predict how this compound interacts with biological targets at an atomic level.

In conclusion, N-(7-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-acetamide(CAS No. 865604-32-6) is a versatile compound with significant potential in pharmaceutical research. Its unique structural features make it an attractive scaffold for developing novel therapeutic agents targeting various diseases. Ongoing research continues to explore its applications in oncology、inflammation、and other therapeutic areas，highlighting its importance as a building block in medicinal chemistry。

• 1123163-33-6(2,2,2-Trifluoro-N-(6-fluoro-imidazo1,2-apyridin-2-yl)-acetamide)
• 2006277-79-6(N-(8-Chloroimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide)
• 2006277-80-9(N-(6-Bromo-8-methylimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide)
• 2006278-09-5(N-(6-Bromo-7-methylimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide)
• 257290-88-3(n-(6-Bromoimidazo1,2-apyrimidin-2-yl)-2,2,2-trifluoroacetamide)
• 504413-26-7(2,2,2-Trifluoro-N-(imidazo1,2-apyridin-2-yl)acetamide)
• 504413-31-4(AcetaMide, 2,2,2-trifluoro-N-(6-forMyliMidazo[1,2-a]pyridin-2-yl)-)
• 947248-69-3(N-(6-Bromo-5-methylimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide)
• 209971-49-3(2,2,2-trifluoro-N-{6-iodoimidazo[1,2-a]pyridin-2-yl}acetamide)
• 504413-35-8(N-{6-bromoimidazo[1,2-a]pyridin-2-yl}-2,2,2-trifluoroacetamide)